Terms: = Head and neck cancer AND uPA AND Treatment
51 results:
1. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
[TBL] [Abstract] [Full Text] [Related]
2. Ulinastatin inhibits the metastasis of nasopharyngeal carcinoma by involving upa/upaR signaling.
Li CZ; Qiang YY; Liu ZJ; Zheng LS; Peng LX; Mei Y; Meng DF; Wei WW; Chen DW; Xu L; Lang YH; Xie P; Peng XS; Wang MD; Guo LL; Shu DT; Ding LY; Lin ST; Luo FF; Wang J; Li SS; Huang BJ; Chen JD; Qian CN
Drug Dev Res; 2023 Nov; 84(7):1468-1481. PubMed ID: 37534761
[TBL] [Abstract] [Full Text] [Related]
3. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid cancer Cell Lines.
Baldini E; Presutti D; Favoriti P; Santini S; Papoff G; Tuccilli C; Carletti R; Di Gioia C; Lori E; Ferent IC; Gagliardi F; Catania A; Pironi D; Tripodi D; D'Andrea V; Sorrenti S; Ruberti G; Ulisse S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409084
[TBL] [Abstract] [Full Text] [Related]
4. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915
[TBL] [Abstract] [Full Text] [Related]
5. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
Sun G; Sui Y; Zhou Y; Ya J; Yuan C; Jiang L; Huang M
J Virol; 2021 Sep; 95(19):e0086121. PubMed ID: 34160253
[TBL] [Abstract] [Full Text] [Related]
6. Role of IGFBP-2 in oral cancer metastasis.
Tsai YF; Chou HC; Liou MH; Liao EC; Cheng CT; Chang SJ; Chan HL
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166143. PubMed ID: 33864954
[TBL] [Abstract] [Full Text] [Related]
7. Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma.
Son SH; Park J; Jung MJ; Lee SK; Kim H; Kim KR; Park KK; Chung WY
Eur J Oral Sci; 2021 Feb; 129(1):e12750. PubMed ID: 33503283
[TBL] [Abstract] [Full Text] [Related]
8. Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.
Peng X; Liu Y; Zhu S; Peng X; Li H; Jiao W; Lin P; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2921-2936. PubMed ID: 31620898
[TBL] [Abstract] [Full Text] [Related]
9. Knockdown of Notch1 inhibits nasopharyngeal carcinoma cell growth and metastasis via downregulation of CCL2, CXCL16, and upa.
Guo H; Wang F; Diao Y; Zhang Z; Chen Q; Qian CN; Keller ET; Zhang J; Lu Y
Mol Carcinog; 2019 Oct; 58(10):1886-1896. PubMed ID: 31270884
[TBL] [Abstract] [Full Text] [Related]
10. Sentinel Lymph Node-Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of head and neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model.
Tanaka Y; Araki K; Tanaka S; Miyagawa Y; Suzuki H; Kamide D; Tomifuji M; Uno K; Kimura E; Yamashita T; Ueda Y; Shiotani A
Mol Cancer Ther; 2019 Aug; 18(8):1430-1438. PubMed ID: 31171582
[TBL] [Abstract] [Full Text] [Related]
11. Diallyl disulfide inhibits the metastasis of type Ⅱ esophageal‑gastric junction adenocarcinoma cells via NF-κB and PI3K/AKT signaling pathways in vitro.
Yin X; Feng C; Han L; Ma Y; Jiao Y; Wang J; Jia L; Jing F; Gao X; Zhang Y; Zhang J
Oncol Rep; 2018 Feb; 39(2):784-794. PubMed ID: 29207122
[TBL] [Abstract] [Full Text] [Related]
12. Anticancer Effects of Colchicine on Hypopharyngeal cancer.
Cho JH; Joo YH; Shin EY; Park EJ; Kim MS
Anticancer Res; 2017 Nov; 37(11):6269-6280. PubMed ID: 29061810
[TBL] [Abstract] [Full Text] [Related]
13. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
[TBL] [Abstract] [Full Text] [Related]
14. upa/upaR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.
Pavón MA; Arroyo-Solera I; Céspedes MV; Casanova I; León X; Mangues R
Oncotarget; 2016 Aug; 7(35):57351-57366. PubMed ID: 27385000
[TBL] [Abstract] [Full Text] [Related]
15. Inhibitory Effects of AVEMAR on Proliferation and Metastasis of Oral cancer Cells.
Yang MD; Chang WS; Tsai CW; Wang MF; Chan YC; Chan KC; Lu MC; Kao AW; Hsu CM; Bau DT
Nutr Cancer; 2016; 68(3):473-80. PubMed ID: 27007465
[TBL] [Abstract] [Full Text] [Related]
16. [All-trans retinoic acid improves iodine uptake of thyroid cancer cells via repressing transcriptional activity of β-catenin].
Lan L; Deng W; Chen HL; Huo LL; Deng LL; Zhang GY; Luo Y
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):553-8. PubMed ID: 26902198
[TBL] [Abstract] [Full Text] [Related]
17. Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression.
Lin CW; Chou YE; Chiou HL; Chen MK; Yang WE; Hsieh MJ; Yang SF
Expert Opin Ther Targets; 2014 Oct; 18(10):1109-20. PubMed ID: 25109417
[TBL] [Abstract] [Full Text] [Related]
18. Up-regulation of urinary-type plasminogen activator correlates with high-risk papillary thyroid carcinoma with BRAF(V600E) mutation and its possible molecular mechanism.
Wakasa T; Li Y; Bai Y; Liu Z; Ozaki T; Mori I; Miyauchi A; Kakudo K; Nakamura M
Pathol Res Pract; 2014 Nov; 210(11):733-8. PubMed ID: 25085839
[TBL] [Abstract] [Full Text] [Related]
19. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.
Bao YN; Cao X; Luo DH; Sun R; Peng LX; Wang L; Yan YP; Zheng LS; Xie P; Cao Y; Liang YY; Zheng FJ; Huang BJ; Xiang YQ; Lv X; Chen QY; Chen MY; Huang PY; Guo L; Mai HQ; Guo X; Zeng YX; Qian CN
Cell Cycle; 2014; 13(12):1958-69. PubMed ID: 24763226
[TBL] [Abstract] [Full Text] [Related]
20. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.
Lescaille G; Menashi S; Cavelier-Balloy B; Khayati F; Quemener C; Podgorniak MP; Naïmi B; Calvo F; Lebbe C; Mourah S
BMC Cancer; 2012 Mar; 12():115. PubMed ID: 22443116
[TBL] [Abstract] [Full Text] [Related]
[Next]
